[PTGX] QoQ Quarter Result on 30-Sep-2019 [#Q3]

Stock
[PTGX] Protagonist Therapeutics, Inc.
Announcement Date
06-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- 43.75%
YoY- -87.85%
Quarter Report
PTGX's Result
PTGX's Financial Summary
View:
Show?
Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 6,217 3,647 2,719 4,141 -8,189 1,560 2,353 91.23%
PBT -18,292 -19,904 -16,645 -16,511 -30,803 -13,920 -14,664 15.89%
Tax 1,129 176 856 -102 -1,629 183 -799 -
NP -19,421 -20,080 -17,501 -16,409 -29,174 -14,103 -13,865 25.21%
Tax Rate - - - - - - - -
Total Cost 25,638 23,727 20,220 20,550 20,985 15,663 16,218 35.74%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin -312.39 -550.59 -643.66 -396.26 356.26 -904.04 -589.25 -34.52%
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
EPS -0.59 -0.72 -0.63 -0.61 -1.18 -0.58 -0.57 2.32%
EPS Diluted -0.59 -0.72 -0.63 -0.61 -1.18 -0.58 -0.57 2.32%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.